Z526- a novel dithiocarbamate-like compound reverses cancer associated cachexia via mitigating NF-B signaling and oxidative ...

In a recent study, researchers demonstrated that Z526, a novel dithiocarbamate-like compound, mitigates cancer-associated cachexia (CAC) both in vitro and in vivo.

In a recent study, researchers demonstrated that Z526, a novel dithiocarbamate-like compound, mitigates cancer-associated cachexia (CAC) both in vitro ...

Pfizer Inc. (NYSE:PFE), one of the world's largest pharmaceutical companies with a market capitalization of $151.25 billion, finds itself at a critical juncture as it navigates the post-pandemic ...

A new study uncovers a novel mechanism through which brown fat is transformed into heat, offering protection against ...

In cancer-associated cachexia, elevated TNF-α and IL-6 exacerbate muscle and fat loss by regulating multiple metabolic signaling pathways, which could be ameliorated by Z526's suppression of NF-κB ...

C2C12 myotubes were treated with CMs of cachectic tumor cells or pro-cachectic inflammatory cytokines in the presence or absence of Z526 at various concentrations for 48 h. (A) The structural formula ...

State Senator Janice Bowling (R) filed Senate Bill 489 today, legislation that would establish a regulated medical marijuana ...